Bard Associates Inc Harrow Health, Inc. Transaction History

Bard Associates Inc

$234 Million
Q1 2025

A detailed history of Bard Associates Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Bard Associates Inc holds 57,300 shares of HROW stock, worth $1.72 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

57,300

Previous 57,500 0.35%

Holding current value

$1.72 Million

Previous $1.93 Million 21.0%

% of portfolio

0.65%

Previous 0.77%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$22.22 - $36.67 $4,444 - $7,334	-200 Reduced 0.35%	57,300 $1.52 Million
Q4 2024 Feb 06, 2025	SELL	$33.39 - $57.5 $40,068 - $69,000	-1,200 Reduced 2.04%	57,500 $1.93 Million
Q3 2024 Nov 06, 2024	SELL	$20.85 - $46.47 $208,083 - $463,770	-9,980 Reduced 14.53%	58,700 $2.64 Million
Q2 2024 Aug 12, 2024	SELL	$10.0 - $21.64 $12,000 - $25,968	-1,200 Reduced 1.72%	68,680 $1.43 Million
Q1 2024 May 13, 2024	BUY	$9.3 - $13.23 $35,619 - $50,670	3,830 Added 5.8%	69,880 $924,000
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $4,860 - $9,816	600 Added 0.92%	66,050 $739,000
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $730,842 - $1.18 Million	-42,075 Reduced 39.13%	65,450 $1.25 Million
Q1 2023 May 12, 2023	SELL	$13.84 - $21.46 $2,768 - $4,292	-200 Reduced 0.19%	107,525 $2.28 Million
Q3 2022 Nov 09, 2022	SELL	$6.57 - $24.88 $11,924 - $45,157	-1,815 Reduced 1.66%	107,725 $1.3 Million
Q2 2022 Aug 11, 2022	BUY	$5.75 - $7.74 $140,300 - $188,856	24,400 Added 28.66%	109,540 $797,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $25,500 - $36,000	-3,000 Reduced 3.4%	85,140 $736,000
Q3 2021 Nov 12, 2021	BUY	$6.99 - $10.6 $12,756 - $19,345	1,825 Added 2.11%	88,140 $801,000
Q2 2021 Aug 12, 2021	BUY	$6.68 - $11.07 $99,699 - $165,219	14,925 Added 20.91%	86,315 $802,000
Q1 2021 May 13, 2021	BUY	$6.26 - $11.03 $87,264 - $153,758	13,940 Added 24.26%	71,390 $482,000
Q4 2019 Feb 13, 2020	BUY	$4.6 - $7.88 $264,270 - $452,706	57,450 New	57,450 $447,000
Q4 2019 Feb 13, 2020	SELL	$4.6 - $7.88 $268,870 - $460,586	-58,450 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $33,741 - $55,200	6,900 Added 13.39%	58,450 $328,000
Q1 2019 May 13, 2019	BUY	$4.75 - $7.1 $244,862 - $366,005	51,550 New	51,550 $257,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.1M

Call Options Held

330K

Put Options Held

670K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $815M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Account

Bard Associates Inc Harrow Health, Inc. Transaction History